Clinical trials: Recurrent Undifferentiated Pleomorphic Sarcoma
- Condition Recurrent Undifferentiated Pleomorphic Sarcoma
- Funder type Industry (pharma, biotech, devices)
Sarcoma
Soblidotin in Treating Patients With Advanced or Metastatic Soft Tissue Sarcoma
RATIONALE: Drugs used in chemotherapy such as soblidotin use different ways to stop tumor cells from dividing so they stop growing or die.
- Trial name
- NCT00064220
- Testing
- soblidotin
- Where
- 6 sites in United States, Puerto Rico
- Sponsor
- Daiichi Sankyo